Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

975 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Historic characteristics and mortality of patients in the Swiss Amyloidosis Registry.
Brouwers S, Heimgartner R, Laptseva N, Aguzzi A, Ehl NF, Fehr T, Hitz F, Jung HH, Kälin J, Manz MG, Müllhaupt B, Ruschitzka F, Seeger H, Stussi G, Zweier M, Flammer AJ, Gerber B, Schwotzer R. Brouwers S, et al. Among authors: gerber b. Swiss Med Wkly. 2024 Feb 15;154:3485. doi: 10.57187/s.3485. Swiss Med Wkly. 2024. PMID: 38579306 Free article.
Acquired haemophilia A in southern Switzerland from 2013 to 2019: a case series.
Ruberti A, Kremer Hovinga JA, Nappi F, Vettese A, Bianchi E, Fernandes E, Galfetti E, Monotti R, Paul P, Regazzoni S, Valente D, Rossi D, Stussi G, Gerber B. Ruberti A, et al. Among authors: gerber b. Swiss Med Wkly. 2023 Mar 31;153:40048. doi: 10.57187/smw.2023.40048. Swiss Med Wkly. 2023. PMID: 37021783 Free article.
Prevalence of amyloid in ligamentum flavum of patients with lumbar spinal stenosis.
Marchi F, Kessler C, Distefano D, Terzi di Bergamo L, Fumagalli L, Averaimo M, Crupi E, Bergamini F, Melli G, Stussi G, Rossi D, Gobbi C, Ripellino P, Pravatà E, Kuhlen DE, Röcken C, Scarone P, Gerber B, Condoluci A. Marchi F, et al. Among authors: gerber b. Amyloid. 2023 Dec;30(4):416-423. doi: 10.1080/13506129.2023.2230516. Epub 2023 Jul 11. Amyloid. 2023. PMID: 37431662
Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology.
Angelillo-Scherrer A, Casini A, Studt JD, Gerber B, Alberio LA, Fontana P. Angelillo-Scherrer A, et al. Among authors: gerber b. Swiss Med Wkly. 2023 Jul 26;153:40113. doi: 10.57187/smw.2023.40113. Swiss Med Wkly. 2023. PMID: 37499160 Free article.
Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates.
Sava M, Bättig V, Gerull S, Passweg JR, Khanna N, Garzoni C, Gerber B, Mueller NJ, Schanz U, Berger C, Chalandon Y, van Delden C, Neofytos D, Stampf S, Franzeck FC, Weisser M; Swiss Transplant Cohort Study. Sava M, et al. Among authors: gerber b. Bone Marrow Transplant. 2023 Jan;58(1):115-118. doi: 10.1038/s41409-022-01851-y. Epub 2022 Oct 30. Bone Marrow Transplant. 2023. PMID: 36310245 Free PMC article. No abstract available.
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials.
Barco S, Virdone S, Götschi A, Ageno W, Arcelus JI, Bingisser R, Colucci G, Cools F, Duerschmied D, Gibbs H, Fumagalli RM, Gerber B, Haas S, Himmelreich JCL, Hobbs R, Hobohm L, Jacobson B, Kayani G, Lopes RD, MacCallum P, Micieli E, Righini M, Robert-Ebadi H, Rocha AT, Rosemann T, Sawhney J, Schellong S, Sebastian T, Spirk D, Stortecky S, Turpie AGG, Voci D, Kucher N, Pieper K, Held U, Kakkar AK; OVID and ETHIC Investigators. Barco S, et al. Among authors: gerber b. Thromb Res. 2023 Oct;230:27-32. doi: 10.1016/j.thromres.2023.08.009. Epub 2023 Aug 18. Thromb Res. 2023. PMID: 37625200 Free article.
Accuracy of Diagnosing Heparin-Induced Thrombocytopenia.
Larsen EL, Nilius H, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Vishnu P, Graf L, Kremer Hovinga JA, Goetze JP, Bakchoul T, Nagler M. Larsen EL, et al. Among authors: gerber b. JAMA Netw Open. 2024 Mar 4;7(3):e243786. doi: 10.1001/jamanetworkopen.2024.3786. JAMA Netw Open. 2024. PMID: 38530310 Free PMC article.
Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial.
Voci D, Götschi A, Held U, Bingisser R, Colucci G, Duerschmied D, Fumagalli RM, Gerber B, Hasse B, Keller DI, Konstantinides SV, Mach F, Rampini SK, Righini M, Robert-Ebadi H, Rosemann T, Roth-Zetzsche S, Sebastian T, Simon NR, Spirk D, Stortecky S, Vaisnora L, Kucher N, Barco S; OVID investigators. Voci D, et al. Among authors: gerber b. Thromb Res. 2023 Jan;221:157-163. doi: 10.1016/j.thromres.2022.10.021. Epub 2022 Nov 12. Thromb Res. 2023. PMID: 36396519 Free PMC article. Clinical Trial.
A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: A prospective, multicenter, observational study.
Nilius H, Cuker A, Haug S, Nakas C, Studt JD, Tsakiris DA, Greinacher A, Mendez A, Schmidt A, Wuillemin WA, Gerber B, Kremer Hovinga JA, Vishnu P, Graf L, Kashev A, Sznitman R, Bakchoul T, Nagler M. Nilius H, et al. Among authors: gerber b. EClinicalMedicine. 2022 Nov 24;55:101745. doi: 10.1016/j.eclinm.2022.101745. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36457646 Free PMC article.
975 results